Genenta delays vote on Saentra Forge name change
Genenta Science S.p.A.
Rhea-AI Filing Summary
Genenta Science S.p.A. (GNTA) reports that its Extraordinary Shareholders’ Meeting held on September 10, 2026, in virtual format did not vote on the proposal to amend Article 1 of its by-laws to change its corporate name to Saentra Forge S.p.A. Shareholders requested a deferral to complete ongoing evaluations of communication, branding, and corporate identity strategy and to allow additional shareholder consultations. The proposal is scheduled to be considered at a reconvened Extraordinary Shareholders’ Meeting on October 8, 2026, at 5:00 p.m. CET.
Positive
- None.
Negative
- None.
Filing Explained
Because the proposed by-law amendment was not put to a vote at the September 10, 2026 meeting, the name change has not taken effect: the company remains Genenta Science S.p.A. pending consideration at the reconvened meeting on October 8, 2026.
Key Figures
Extraordinary Shareholders’ Meeting date: September 10, 2026
Reconvened meeting date: October 8, 2026
Reconvened meeting time: 5:00 p.m. CET
+1 more
4 metrics
Extraordinary Shareholders’ Meeting date
September 10, 2026
Date the Extraordinary Shareholders’ Meeting was held in virtual format
Reconvened meeting date
October 8, 2026
Date scheduled to reconsider the name change proposal
Reconvened meeting time
5:00 p.m. CET
Time of the reconvened Extraordinary Shareholders’ Meeting on October 8, 2026
Form S-8 file number
333-278392
Registration statement into which this Form 6-K is incorporated by reference
Key Terms
Extraordinary Shareholders’ Meeting, by-laws, Form 6-K, Form S-8, +2 more
6 terms
by-laws regulatory
"the proposal to amend Article 1 of the Company’s by-laws to change the Company’s corporate name"
By-laws are the internal rules a corporation uses to run itself—how directors are chosen, how meetings are run, what officers do, and how voting and record-keeping work. For investors, by-laws matter because they shape who controls decisions, how easily management can be changed, and what rights shareholders have; think of them as the company’s operating manual that can influence governance, risk and the value of your stake.
Form 6-K regulatory
"This report on Form 6-K is incorporated by reference"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
Form S-8 regulatory
"incorporated by reference into the registrant’s registration statement on Form S-8"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
forward-looking statements regulatory
"This Report on Form 6-K contains forward-looking statements that involve risks and uncertainties"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Form 20-F regulatory
"These risks are described in the Company’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Genenta Science S.p.A. (GNTA) announce in this Form 6-K?
Genenta Science S.p.A. announced that its September 10, 2026 Extraordinary Shareholders’ Meeting did not vote on a proposed corporate name change and that the proposal will instead be considered at a reconvened meeting on October 8, 2026 at 5:00 p.m. CET.
Why was the GNTA corporate name change proposal not voted on?
The proposal to change the corporate name from Genenta Science S.p.A. to Saentra Forge S.p.A. was deferred at shareholders’ request to allow completion of ongoing evaluations of the Company’s communication, branding, and corporate identity strategy and to provide additional time for shareholder consultations.
When will Genenta Science (GNTA) reconsider the name change to Saentra Forge S.p.A.?
The name change proposal will be considered at a reconvened Extraordinary Shareholders’ Meeting scheduled for October 8, 2026, at 5:00 p.m. CET.
What corporate change is being proposed for Genenta Science S.p.A. (GNTA)?
The proposed change is an amendment to Article 1 of the Company’s by-laws to change its corporate name from Genenta Science S.p.A. to Saentra Forge S.p.A..
What forward-looking information does Genenta Science (GNTA) highlight in this filing?
The Company identifies forward-looking statements regarding the reconvened Extraordinary Shareholders’ Meeting, the proposed corporate name change, and aspects of its business strategy, strategic initiatives, and future plans, and cautions that actual results may differ due to risks described in its Form 20-F and other reports.
AI-generated analysis. How Rhea-AI works. Not financial advice.
